A groundbreaking study published in the journal Aging Cell suggests that the widely used drug rapamycin may offer life-extending benefits comparable to those achieved through calorie restriction, without the need for harsh dietary changes. Calorie restriction, often practiced through intermittent fasting, has long been regarded as the gold standard for increasing longevity. However, maintaining such diets over the long term has proven unsustainable for many.
The study brings new attention to the growing interest in rapamycin lifespan extension, offering a potential alternative that doesn’t require drastic changes in eating habits.
Researchers at the University of East Anglia and other institutions conducted a large-scale analysis to determine whether anti-aging drugs like rapamycin could offer a more practical alternative.
Zahida Sultanova, a researcher involved in the study, noted that while calorie-cutting has strong scientific backing, most people find it difficult to stick with. “We wanted to know if popular anti-aging drugs like rapamycin or metformin could offer similar effects without the need to cut calories,” she said. The findings could signal a major shift in how scientists and the public approach the concept of healthy aging, especially with emerging evidence around rapamycin lifespan extension.
Comprehensive Study Yields Striking Results
The team conducted a meta-analysis of 167 studies across eight different vertebrate species, including primates, rodents, and fish. They discovered that rapamycin’s lifespan extension effects were strikingly similar to the benefits seen in animals undergoing severe calorie restriction. While metformin, another popular anti-aging candidate, did not show the same impact, rapamycin emerged as a compelling alternative.
Rapamycin, first discovered in soil samples from Easter Island in the 1970s, was originally used as an immunosuppressant to prevent organ rejection in transplant patients. It works by inhibiting the mTOR pathway — a critical regulator of cell growth, repair, and autophagy (a process that helps clean out damaged cells). This mechanism appears to mimic the cellular responses typically triggered by fasting. Despite being FDA-approved for medical use in transplant cases, rapamycin is not currently approved for anti-aging use in humans.
Promise and Caution in Equal Measure
While the research raises hopes about rapamycin’s role in extending human lifespan, experts caution against self-medication. Study co-author Edward Ivimey-Cook emphasized that the findings should not encourage people to start taking rapamycin without medical supervision. “They do strengthen the case for its further study in aging research and raise important questions about how we approach longevity therapeutics,” he said.
Low doses of rapamycin appear to be relatively safe, and in the context of rapamycin lifespan extension, the drug does come with potential risks, including immune suppression, which could raise the likelihood of infections.” Common side effects include headaches, chills, joint pain, nausea, and mouth sores. High-profile biohacker Bryan Johnson, who once incorporated the drug into his regimen, has since stopped due to side effects such as elevated blood sugar and increased resting heart rate.
Sultanova concluded that the study ‘shows that drug repurposing is a promising approach to improving people’s health and lifespan,’ but underlined the need for further research before rapamycin lifespan extension could become a widely accepted longevity therapy.
Visit The Lifesciences Magazine to read more.
